Investigation of a Mechanical Valve Impairment after Eight Years of Implantation

Abstract:

A 55-year-old female who undergone mitral valve replacement eight years ago with a mechanical graft, presented accusing sudden decrease of effort tolerance and two episodes of pulmonary edema in the last month. Anamnesis, physical examination, electrocardiogram (ECG), transthoracic echocardiography and coronarography were performed. The mechanical valve leaflets and the tissue surrounding the prosthetic ring were evaluated by: optical microscopy (hematoxylin eosin stain and immunohistochemistry), scanning electron microscopy (SEM) and EDAX analysis (Energy Dispersive X-ray spectroscopy). Anamnesis: inferior myocardial infarction in 2006, congestive cardiac insufficiency, pulmonary hypertension, and arterial hypertension. Clinical examination and ECG: minimal perimaleolar edema bilateral, sinus rhythm on admission. Transthoracic echocardiography: 55% ejection fraction, a pression gradient across the mitral valve (Gmax/Gmed= 24/11 mmHg), tricuspid regurgitation, and pulmonary hypertension. A mitral prosthetic valve’s leaflet was found immobile. No thrombus was evidenced. Coronarography: an immobile graft’s leaflet, stenoses on the right coronary artery, stenosis on left anterior descending artery and occlusion at the circumflex artery emergence. The prosthesis was replaced, and two coronary artery bypasses were performed. Macroscopic examination: a fibroconjunctive tissue expansion in close contact with the leaflet. Histopathological evaluation: muscle cells with altered phenotypes, fibroblasts along with fibrous connective tissue and calcium depots areas. SEM evaluation: tissue depots on the immobile leaflet, suggesting that the connective tissue expansion was blocking the leaflet’s movements. EDAX analysis: the metallic leaflets surface was made of tantalum; sodium, calcium and chloride deposits were also detected. Graft failure was caused by the tissue proliferation affecting leaflet’s mobility. SEM is a viable method for failed cardiovascular grafts investigation.

• Periodical: Key Engineering Materials (Volume 583)
• Pages: 137-144
• DOI: https://doi.org/10.4028/www.scientific.net/KEM.583.137
• Online since: September 2013
• Authors: Cosmin Alexandru Buzila, Iulian Antoniac, Florin Miculescu, Marius Dumitrescu, Ionel Droc
• Keywords: Mechanical Valve Prosthesis Failure, Mitral Valve Replacement, Scanning Electron Microscope (SEM)

References

[1] Emery R.W., Van Nooten G.J., Tesar P.J., The initial experience with the ATS Medical mechanical cardiac valve prosthesis, Ann Thorac Surg 2003; 75: 444-452.

DOI: 10.1016/s0003-4975(02)04537-x

[2] Shi J., Bai Z., Hu J., Zhang B., Guo Y., Rare early prosthesis obstruction after mitral valve replacement: a case report and literature review, Journal of Cardiothoracic Surgery 2012, 7: 64.

DOI: 10.1186/1749-8090-7-64

[3] Jessup M., Abraham W.T., Casey D.E., et al., 2009 Focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation, Circulation 2009; 119: 1977-(2016).

DOI: 10.1161/circulationaha.109.192064

[4] Ryan J.J., T. Thenappan, N. Luo, T. Ha, A.R. Patel, S. Rich, S.L. Archer, The WHO classification of pulmonary hypertension: A case-based imaging compendium, Pulm Circ. 2012 Jan; 2(1): 107-21.

DOI: 10.4103/2045-8932.94843

[5] Chobanian  A.V., Bakris  G.L., Black  H.R., Cushman  W.C., Green  L.A., J.L. Izzo Jr., et al., and the National High Blood Pressure Education Program Coordinating Committee, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure., The JNC 7 Report., JAMA 2003; 289: 2560-72.

DOI: 10.1161/01.hyp.0000107251.49515.c2

[6] The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, 9th ed. Boston, Mass: Little, Brown & Co; 1994: 253-256.

DOI: 10.1097/00000441-196406000-00028

[7] Shibataa T., Inoueb K., Ikutab T., Bitob Y., Yoshiokab Y., Mizoguchi H., Which valve and which size should we use in the valve-on-valve technique for re-do mitral valve surgery?, Interactive CardioVascular and Thoracic Surgery 8 (2009) 206–210.

DOI: 10.1510/icvts.2008.187666

[8] Goebel H.H., Warlo I.A.P., Progress in desmin-related myopathies (review), J Child Neurol 2000; 15: 565-72.

DOI: 10.1177/088307380001500901

[9] Rizzoli G., Guglielmi C., Toscano G., et al: Reoperations for acute prosthetic thrombosis and pannus: an assessment of rates, relationship and risk, Eur J Cardiothorac Surg 1999, 16: 74–80.

DOI: 10.1016/s1010-7940(99)00124-4

[10] Barbetseas J., Nagueh S.F., Pitsavos C., Toutouzas P.K., Quiñones M.A., Zoghbi W.A., Differentiating thrombus from pannus formation in obstructed mechanical prosthetic valves: an evaluation of clinical, transthoracic and transesophageal echocardiographic parameters, J Am Coll Cardiol 1998, 32: 1410–1417.

DOI: 10.1016/s0735-1097(98)00385-4

[11] Mullenix P.S., Parsa C.J., Mackensen G.B., Jollis J.G., Harrison J.K., Hughes G.C.: Pannus-related prosthetic valve dysfunction and life-threatening aortic regurgitation. J Heart Valve Dis 2008, 17: 666–669.

[12] Rangdaeng S., Truong L.D., Comparative immunohistochemical staining for desmin and muscle-specific actin. A study of 576 cases, Am J Clin Pathol. 1991 Jul; 96(1): 32-45.

DOI: 10.1093/ajcp/96.1.32

[13] Grigore A., Arsene D., F Filipoiu., Cionca F., Enache S., Ceaușu M., Comǎnescu M., Stǎniceanu F., Ardeleanu C., Cellular immunophenotypes in human embryonic, fetal and adult heart, Rom J Morphol Embryol 2012, 53(2): 299–311.

[14] Naq A.C., Krehel W., Cheng M., Distribution of vimentin and desmin filaments in embryonic cardiac muscle cells in culture, Cytobios, 1986, 45(182–183): 195–209.

[15] McLendon P.M., Robbins J., Desmin-related cardiomyopathy: an unfolding story, Am J Physiol Heart Circ Physiol, 2011, 301(4): H1220–H1228.

DOI: 10.1152/ajpheart.00601.2011

[16] Capetanaki Y., Desmin cytoskeleton: a potential regulator of muscle mitochondrial behavior and function, Trends Cardiovasc Med, 2002, 12(8): 339–348.

DOI: 10.1016/s1050-1738(02)00184-6

[17] Guo X., Chen M., Feng W., Liang J., Zhao H., Tian L., Chao H., Zou X., Electrostatic self-assembly of multilayer copolymeric membranes on the surface of porous tantalum implants for sustained release of doxorubicin, Int J Nanomedicine. 2011; 6: 3057-64.

DOI: 10.2147/ijn.s25918

[18] Teshima H., Hayashida N., Yano H., et al, Obstruction of St Jude Medical valves in the aortic position: histology and immunohistochemistry of pannus, J Thorac Cardiovasc Surg 2003, 126: 401–407.

DOI: 10.1016/s0022-5223(03)00702-5

[19] Teshima H., Fukunaga S., Takaseya T., Tomoeda H., Akashi H., Aoyagi S.: Obstruction of St. Jude medical valves in the aortic position: plasma transforming growth factor type beta 1 in patients with pannus overgrowth. Artif Organs 2010, 34: 210–215.

DOI: 10.1111/j.1525-1594.2009.00800.x